Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02089217 · ClinicalTrials.gov registry record · NA
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 2,486
- Enrollment target
NCT02089217: Completed NA study, sponsored by Mayo Clinic.
NCT02089217 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 2,486 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02089217, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,486 participants
- Enrollment target
Study Summary
Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multicenter, randomized controlled trials of carotid revascularization and intensive medical management versus medical management alone in patients with asymptomatic high-grade carotid stenosis. One trial will randomize patients in a 1:1 ratio to endarterectomy versus no endarterectomy and another will randomize patients in a 1:1 ratio to carotid stenting with embolic protection versus no stenting. Medical management will be uniform for all randomized treatment groups and will be centrally directed.
Interventions
- PROCEDURE Carotid endarterectomy (CEA)
- DEVICE Carotid Stenting (CAS)
- OTHER Intensive Medical Management - no CEA
- OTHER Intensive Medical Management - no CAS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,486 participants |
| Start Date | 2014-12-09 |
| Est. Completion | 2025-09-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02089217
The ClinicalTrials.gov registry entry for NCT02089217 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,486 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Carotid endarterectomy (CEA) is the first listed.
NCT02089217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02089217 about?
NCT02089217 is a clinical study titled "Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial". Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multicenter, randomized controlled trials of carotid revascularization and intensive medical management versus medical management alone in patients with asymptomatic high-grade carotid stenosis. One trial will ra...
What is the current status of trial NCT02089217?
This trial is currently completed. It is a NA study. The enrollment target is 2,486 participants. The study started on 2014-12-09. Estimated completion is 2025-09-12.
What interventions are being tested in trial NCT02089217?
The interventions under investigation include: Carotid endarterectomy (CEA) (PROCEDURE), Carotid Stenting (CAS) (DEVICE), Intensive Medical Management - no CEA (OTHER), Intensive Medical Management - no CAS (OTHER).
Who is sponsoring clinical trial NCT02089217?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.